| ACC | Adrenocortical Carcinoma |
| AD | Adenocarcinoma |
| AML | Acute Myeloid Leukemia |
| BLC | Bladder Urothelial Carcinoma |
| BLGG | Brain Lower Grade Glioma |
| BRCA | Breast Invasive Carcinoma |
| CC | Cervical Cancer |
| DFS | Disease Free Survival |
| DLBL | Diffuse Large B-cell Lymphoma |
| FFPE | Formalin-Fixed Paraffin-Embedded |
| GBM | Glioblastoma Multiforme |
| H&N | Head and Neck |
| HCC | Hepatocellular Carcinoma |
| HSP | Heat Shock Protein |
| IHC | Immunohistochemistry |
| KICH | Kidney Chromophobe |
| KIRP | Kidney Renal Papillary Cell Carcinoma |
| mAb | Monoclonal Antibody |
| NSCLC | Non-Small Cell Lung Carcinoma |
| OS | Overall Survival |
| OV | Ovarian Serous Cystadenocarcinoma |
| pAb | Polyclonal Antibody |
| PCPG | Pheochromocytoma and Paraganglioma |
| PRECOG | PREdiction of Clinical Outcomes from Genomic Profiles |
| RFS | Relapse Free Survival |
| SARC | Sarcoma |
| SCC | Squamous Cell Carcinoma |
| SKCM | Skin Cutaneous Melanoma |
| TCGA | The Cancer Genome Atlas |
| THCA | Thyroid carcinoma |
| UCEC | Uterine Corpus Endometrial Carcinoma |
| UCS | Uterine Carcinosarcoma |